ÌÇÐÄÔ­´´

From scientific setback to meaningful discovery; an unexpected journey 

What makes research meaningful? 

It is a question I have reflected on often throughout my career. Twenty-one years ago, after spending several years developing a vaccine strategy based on a molecule called the mannose receptor (CD206), I discovered that our promising findings in mice were unlikely to translate directly to humans. The human version of CD206 was distributed very differently, raising doubts about whether the approach would ever work in the clinic. 

At the time, the discovery felt like a setback. It forced me to reconsider my research direction and pushed me towards human-centred studies, despite having few clinical connections and little idea of where that path might lead. Looking back, it was a pivotal moment. 

Today, in collaboration with Professor Marco Oggioni and colleagues, we have demonstrated that human CD206 plays a critical role in clearing pathogenic bacteria from the bloodstream. The findings build directly on observations I first made more than two decades ago. It has taken a long time to understand their significance, but being part of the team that finally unlocked their meaning has been incredibly rewarding. 

Learning from differences 

Much of what we know about the immune system comes from studies in animal models. They help us understand how the body responds to infection, how vaccines work and how different factors influence health. These insights often provide the starting point for discoveries in humans. 

One organ that has fascinated me throughout my career is the spleen. Although it receives less attention than organs such as the heart or lungs, it plays a vital role in fighting infection by producing antibodies and filtering harmful bacteria from the bloodstream. These functions are shared between mice and humans, making the mice a valuable system for study. 

Early in my career, I studied how certain immune cells in the mouse spleen interact with CD206. Our research suggested that targeting this pathway could improve vaccine responses. The results were encouraging; by targeting this pathway, we were able to enhance antibody responses in mice. At the time, I imagined a future spent refining this technology and exploring the biology of these fascinating cells. 

A disappointing discovery 

Eager to explore the relevance of our findings in humans, I began examining human spleen tissue. What I found was unexpected. 

The biological arrangement that supported our vaccine strategy in mice simply did not exist in the same way in humans. Instead, the cells that interact with CD206 also produce it and were distributed throughout much of the human spleen. Rather than helping generate vaccine responses as we had expected, these cells seemed to be involved in filtering the bloodstream. 

It was a disappointing realisation. The translational path I had imagined suddenly seemed far less certain. Yet that unexpected observation opened the door to a different set of questions.

Following the science 

Years later, I began collaborating with Professor Oggioni, whose research focuses on bacterial infections and the role of the spleen in clearing pathogens from the bloodstream. 

Together, we explored how bacteria are captured and removed by the spleen, and what happens when this process goes wrong. In mouse studies, we discovered that the specialised immune cells that bound CD206 could provide a place where the bacterium Streptococcus pneumoniae (a major cause of sepsis) could survive and multiply. This finding offered new insights into why some infections are difficult to eliminate, even with antibiotic treatment. 

Given the anatomical differences between mouse and human spleens, it was essential to determine whether similar mechanisms operated in people. This was a particularly challenging question to answer. Understanding the filtering capacity of the human spleen required access to whole organs and expertise spanning multiple disciplines. 

The project ultimately brought together researchers across three universities and two countries. Thanks to this collaborative effort, we demonstrated that human CD206 is a key component of the spleen's ability to remove disease-causing encapsulated bacteria from the bloodstream. 

The same molecular players were present in mice and humans, but they were being used in different ways.

Looking back, the findings that once seemed to derail my research ultimately gave it new purpose. More than two decades later, I understand their significance in a way I never could at the beginning.

Looking back—and forward 

Publishing these findings has prompted me to reflect on the unpredictable nature of research. 

My early work helped identify immune cells that both support antibody production and, paradoxically, can act as vulnerabilities within the immune system. Looking back, I can see opportunities that I did not pursue at the time. Perhaps my original CD206-based targeting strategy could function in other human immune organs, such as lymph nodes. It is a question still worth exploring. 

Our more recent work provides a framework for investigating how bacterial clearance by the human spleen might be enhanced, potentially offering new approaches to protecting vulnerable patients from bloodstream infections. 

Most of all, it has made me wonder why I did not follow these observations sooner. What barriers, real or imagined, prevented me from exploring the role of CD206 in the human spleen all those years ago? 

Research rarely follows a neat, linear path. Progress depends on curiosity, persistence and, often, a willingness to revisit questions that once seemed to lead nowhere. 

Being part of this collaboration has reminded me that unexpected results are not always obstacles. Sometimes they encourage us to ask better questions. Sometimes they send us in directions we never anticipated. 

Looking back, the findings that once seemed to derail my research ultimately gave it new purpose. More than two decades later, I understand their significance in a way I never could at the beginning. 

As for what comes next? There are still many unanswered questions. But that is one of the things that makes research meaningful: the possibility that the next unexpected finding could open an entirely new path forward.